A pharmaceutical-grade cannabidiol (CBD) product was shown to be safe in high-risk patients hospitalized with COVID-19, with ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

Key take-awaysCannabidiol – which lacks the psychotropic effects of cannabis – has been shown to have beneficial effects on ...

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and ...

The illness raises the likelihood that children develop chronic kidney disease, irritable bowel syndrome and cardiovascular issues, Penn researchers say.

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to ...

Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated ...